Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C Read more about Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C
NCI COVID-19 in Cancer Patients, NCCAPS Study Read more about NCI COVID-19 in Cancer Patients, NCCAPS Study
Feasibility of a Self-guided Exercise Program Among Hospitalized COVID-19 Patients Read more about Feasibility of a Self-guided Exercise Program Among Hospitalized COVID-19 Patients
PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL Read more about PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATL) Read more about Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATL)
Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo Read more about Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo
Reducing Time to Spaced-out Appointments for Newly-diagnosed People Living With HIV Read more about Reducing Time to Spaced-out Appointments for Newly-diagnosed People Living With HIV
Home-Based Covid-19 Rehabilitation Program Read more about Home-Based Covid-19 Rehabilitation Program
Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) Read more about Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)